Mezzion Pharma Co.,Ltd.

₩62,600As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:140410Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 24.44%
Div yield —
ROE (68.28%)
Medical (Pharmaceuticals)
Beta (5Y) 1.27
PE TTM —
TSR TTM 1.13%
Mkt cap ₩1.916T
ROIC (142.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩67,614
8.01%
(50.57%)
Hold 3|8|6|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
819.13
895.58
972.75
1,038
8.86%
15.89%
18.98%
31.03%
Revenue₩B
103.4
106.4
105.4
103.2
13.05%
11.08%
11.15%
5.39%
Peers (US$1.413B)
Cap (US$)
PE
1.796B
14.03x
1.117B
19.92x
1.024B
14.77x
Capital
TTM
5Y
10Y
Leveragex
11.86
0.158
0.152
EBIT/Intx
0.744
0.994
0.886
Own earn%
(20.43)
231.15
230.86
Sh yield%
56.72
20.52
22.73
Owners
Insiders/Inst%
2.72
78.52
Short interest%
5.67
SBC / revenue%
1.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
13–19
$1 testx
2.2
Incr. ROIC%
8